Chaoju Eye Care Holdings Limited reported no change in its issued share capital as at 30 June 2026, which remains at 705.18 million ordinary shares with no treasury shares on hand.

Share repurchase status • Between 2 April and 30 June 2026 the group bought back 1.28 million shares on the Hong Kong Stock Exchange at prices ranging from HKD 2.43 to HKD 3.02 per share. • All repurchased shares are pending cancellation, equivalent to approximately 0.18 % of the current issued share base. • The latest daily transaction, executed on 30 June 2026, involved 60,000 shares at between HKD 2.40 and HKD 2.45, costing HKD 0.15 million.

Repurchase mandate utilisation • A fresh shareholder mandate obtained on 12 May 2026 authorises the repurchase of up to 70.52 million shares. • Since the mandate date, Chaoju Eye Care has acquired 0.90 million shares, using 0.13 % of the authorised limit. • Following the latest repurchase, the company is subject to a 30-day moratorium—until 30 July 2026—on issuing new shares or re-selling any treasury shares.

Capital position • Post-repurchase, the total number of issued shares will decline to roughly 703.90 million once the 1.28 million shares are formally cancelled, assuming no further changes.

Governance confirmation The board affirmed that all repurchases were conducted in accordance with Hong Kong listing rules and relevant legal requirements, with full payment completed for the acquired shares.